Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 3, 2005, Pages 1355-1360

  Pelorosso, Facundo Germán ^a   Brodsky, Paula Tamara ^a   Zold, Camila Lidia ^a   Rothlin, Rodolfo Pedro ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Paraguay 2155 ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMASTATIN; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ[SARCOSINE 8 DEXTRO PHENYLALANINE 9 DEARGININE]; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KALLIDIN[1-9]; KALLIDIN[8 LEUCINE 9 DEARGININE]; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE; MICROSOMAL AMINOPEPTIDASE; PHOSPHORAMIDON; UNCLASSIFIED DRUG; BRADYKININ B1 RECEPTOR; DRUG DERIVATIVE; KALLIDIN; KALLIDIN, DES ARG(10); KALLIDIN, DES-ARG(10)-; PROTEINASE INHIBITOR;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG METABOLISM; DRUG POTENTIATION; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; UMBILICAL ARTERY; VASOCONSTRICTION; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY;

ANTIGENS, CD13; CAPTOPRIL; DRUG SYNERGISM; HUMANS; KALLIDIN; NEPRILYSIN; PROTEASE INHIBITORS; RECEPTOR, BRADYKININ B1; UMBILICAL ARTERIES; VASOCONSTRICTION;

EID: 19444387829     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.105.083063     Document Type: Article

References (40)

1. Abbas F, Clayton JK, Marshall KM, and Senior J (1998) Characterisation of kinin receptors on the human isolated umbilical artery. J Endocrinol 156:389-394.
2. Altura BM, Malaviya D, Reich CF, and Orkin LR (1972) Effects of vasoactive agents on isolated human umbilical arteries and veins. Am J Physiol 222:345-355.
3. Arnal JF, Battle T, Rasetti C, Challah M, Costerousse O, Vicaut E, Michel JB, and Alhenc-Gelas F (1994) ACE in three tunicae of rat aorta: Expression in smooth muscle and effect of renovascular hypertension. Am J Physiol 267:H1777-H1784.
4. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48-58.
5. Babiuk C, Marceau F, St-Pierre S, and Regoli D (1982) Kininases and vascular responses to kinins. Eur J Pharmacol 78:167-174.
6. Bathon JM and Proud D (1991) Bradykinin antagonists. Annu Rev Pharmacol Toxicol 31:129-162.
7. deBlois D and Horlick RA (2001) Endotoxin sensitization to kinin B(1) receptor agonist in a non-human primate model: haemodynamic and pro-inflammatory effects. Br J Pharmacol 132:327-335.
8. DeLean A, Munson PJ, and Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves. Am J Physiol 235:E97-E102.
9. Drapeau G, Audet R, Levesque L, Godin D, and Marceau F (1993) Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. J Pharmacol Exp Ther 266:192-199.
10. 9-bradykinin and metabolically protected agonists of B1 receptors for kinins. J Pharmacol Exp Ther 259:997-1003.
11. Dray A and Perkins M (1993) Bradykinin and inflammatory pain. Trends Neurosci 16:99-104.
12. Emanueli C, Bonaria Salis M, Stacca T, Pintus G, Kirchmair R, Isner JM, Pinna A, Gaspa L, Regoli D, Cayla C, et al. (2002) Targeting kinin B(1) receptor for therapeutic neovascularization. Circulation 105:360-366.
13. Erdos EG (1990) Some old and some new ideas on kinin metabolism. J Cardiovasc Pharmacol 15 (Suppl 6):S20-S24.
14. Fortin JP, Gobeil F Jr, Adam A, Regoli D, and Marceau F (2003) Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor? Am J Physiol Heart Circ Physiol 285:H277-H282.
15. Frossard N, Stretton CD, and Barnes PJ (1990) Modulation of bradykinin responses in airway smooth muscle by epithelial enzymes. Agents Actions 31:204-209.
16. Gafford JT, Skidgel RA, Erdos EG, and Hersh LB (1983) Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 22:3265-3271.
17. Gonzalez W, Soleilhac JM, Fournie-Zaluski MC, Roques BP, and Michel JB (1998) Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels. Eur J Pharmacol 345:323-331.
18. Huang TJ, Haddad EB, Fox AJ, Salmon M, Jones C, Burgess G, and Chung KF (1999) Contribution of bradykinin B(1) and B(2) receptors in allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med 160:1717-1723.
19. Ignjatovic T, Tan F, Brovkovych V, Skidgel RA, and Erdos EG (2002) Activation of bradykinin B1 receptor by ACE inhibitors. Int Immunopharmacol 2:1787-1793.
20. Kenakin TP (1992) Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions. Mol Pharmacol 41:699-707.
21. Kerr MA and Kenny AJ (1974) The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem J 137:477-488.
22. Kokkonen JO, Kuoppala A, Saarinen J, Lindstedt KA, and Kovanen PT (1999) Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase. Circulation 99:1984-1990.
23. Lagneux C, Adam A, and Lamontagne D (2003) A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart. Int Immunopharmacol 3:1511-1518.
24. Li Q, Feenstra M, Pfaffendorf M, Eijsman L, and van Zwieten PA (1997) Comparative vasoconstrictor effects of angiotensin II, III and IV in human isolated saphenous vein. J Cardiovasc Pharmacol 29:451-456.
25. Llorens-Cortes C, Huang H, Vicart P, Gasc JM, Paulin D, and Corvol P (1992) Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. J Biol Chem 267:14012-14018.
26. Marceau F, Hess JF, and Bachvarov DR (1998) The B1 receptors for kinins. Pharmacol Rev 50:357-386.
27. McEachern AB, Shelton ER, Bhakta S, Obernolte R, Bach C, Zuppan P, Fujisaki J, Aldrich RW, and Jarnagin K (1991) Expression cloning of a rat B2 bradykinin receptor. Proc Natl Acad Sci USA 88:7724-7728.
28. Menke JG, Borkowski JA, Bierilo KK, MacNeil T, Derrick AW, Schneck KA, Ransom RW, Strader CD, Linemeyer DL, and Hess JF (1994) Expression cloning of a human B1 bradykinin receptor. J Biol Chem 269:21583-21586.
29. Miyamoto A, Murata S, and Nishio A (2002) Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery. Naunyn-Schmiedeberg's Arch Pharmacol 365:365-370.
30. Palmieri FE, Bausback HH, and Ward PE (1989) Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M. Biochem Pharmacol 38:173-180.
31. 1 receptors. Proc Natl Acad Sci USA 97:8140-8145.
32. Proud D, Baumgarten CR, Naclerio RM, and Ward PE (1987) Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J Immunol 138:428-434.
33. Regoli D, Barabe J, and Park WK (1977) Receptors for bradykinin in rabbit aortae. Can J Physiol Pharmacol 55:855-867.
34. Regoli D, Marceau F, and Barabe J (1978) De novo formation of vascular receptors for bradykinin. Can J Physiol Pharmacol 56:674-677.
35. Robertson MJ, Cunoosamy MP, and Clark KL (1992) Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta. Br J Pharmacol 106:166-172.
36. Sardi SP, Errasti AE, Rey-Ares V, Rogines-Velo MP, and Rothlin RP (2000) Bradykinin B1 receptor in isolated human umbilical vein: an experimental model of the in vitro up-regulation process. Acta Pharmacol Sin 21:105-110.
37. Skeggs L, Kahn J, and Shumway N (1956) The preparation and function of the hypertensin-converting enzyme. J Exp Med 103:295-299.
38. Tschope C, Spillmann F, Altmann C, Koch M, Westermann D, Dhayat N, Dhayat S, Bascands JL, Gera L, Hoffmann S, et al. (2004) The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction. Cardiovasc Res 61:559-569.
39. Tufan H, Ayan-Polat B, Tecder-Unal M, Polat G, Kayhan Z, and Ogus E (2003) Contractile responses of the human umbilical artery to KCl and serotonin in Ca-free medium and the effects of levcromakalim. Life Sci 72:1321-1329.
40. Walsh DA, Mapp PI, Wharton J, Polak JM, and Blake DR (1993) Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 142:1610-1621.